Dr Raymond Jung, PHARMD | |
441 N Lakeview Ave, Anaheim, CA 92807-3028 | |
(714) 279-4380 | |
(714) 279-5200 |
Full Name | Dr Raymond Jung |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 441 N Lakeview Ave, Anaheim, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447330220 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 28925 (California) | Primary |
183500000X | Pharmacist | 0006940 (Oregon) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Raymond Jung, PHARMD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (714) 279-4380 | Dr Raymond Jung, PHARMD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (714) 279-4380 |
News Archive
Mobile interoperability leader AirStrip and Telenatal have announced a strategic partnership to begin distributing AirStrip's Sense4Baby wireless fetal/maternal monitoring system in 13 European countries.
As lawmakers continue to wrestle with how best to reform the Medicare physician payment system, the results of a new survey by the American Association of Neurological Surgeons (AANS), the Congress of Neurological Surgeons (CNS), and the Council of State Neurosurgical Societies (CSNS) paint a troubling picture for patients if drastic Medicare physician payment cuts continue.
Picture a bare wire, without its regular plastic coating. It's exposed to the elements and risks being degraded. And, without insulation, it may not conduct electricity as well as a coated wire. Now, imagine this wire is inside your brain.
It may seem obvious, but the key to confirming whether someone is suffering from a cold or flu virus might lie at the misery's source - the inflamed passages of the nose and throat.
KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers of its novel prodrug compound, KP106, which is in development for the treatment of attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of d-amphetamine and a ligand, is the lead investigational candidate from KemPharm's proprietary ligand activated therapy (LAT) platform, which creates improved versions of FDA-approved drugs. KemPharm began the KP106 program in 2007 and has initiated the Phase 1 clinical trial of this candidate in less than 24 months.
› Verified 5 days ago
Tarjani Lalitkumar Padmani, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 735 S Dove Tree Ln, Anaheim, CA 92808 Phone: 714-280-0825 | |
John Wang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 88 E Orangethorpe Ave, Anaheim, CA 92801 Phone: 714-626-0014 | |
Mohamed Hussein, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1807 W Katella Ave Ste 206, Anaheim, CA 92804 Phone: 714-733-7978 Fax: 714-733-7969 | |
Kasey Kim, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1425 E Lincoln Ave Ste B, Anaheim, CA 92805 Phone: 714-776-1020 Fax: 714-776-7053 | |
Dr. Lan-phuong Nguyen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 411 N Lakeview Ave, Kaiser Permanente Anticoagulation Service, Anaheim, CA 92807 Phone: 714-279-5403 Fax: 714-279-4809 | |
Hanny M Tadros, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 611 S Brookhurst St, Anaheim, CA 92804 Phone: 714-778-3123 | |
Atoussa Najafian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 440 N Euclid St, Anaheim, CA 92801 Phone: 714-491-1778 |